Cardiovascular Monitoring and Diagnostic Devices Market - current status and future directions.

Intense competition and high entry barriers outline the present state of the competitive landscape of the global cardiovascular monitoring and diagnostic devices market, states a recent Transparency Market Research (TMR) report. In the markedly consolidated market, the top two vendors, GE Healthcare and Philips Healthcare, accounted for a more than 55% share in 2015. Moreover, these two companies have their headquarters in Europe, granting this regional market a high level of saturation. The other half of the competitive landscape is, however, highly fragmented with a large number of specialty vendors operating in regional pockets.

However, the rising prevalence of a number of cardiovascular diseases coupled with the rising global demand for technologically advanced and innovative devices would attract new entrants to the market. As a result, the competition in the market is expected to further intensify in the next few years. Pulling ahead in these foreseeable tough times will require alignment of business strategies towards untapped opportunities in several regional territories and innovative ways of promoting products. Other key vendors operating in the global cardiovascular monitoring and diagnostic devices market include Spacelabs Healthcare, St. Jude Medical, Inc., and Siemens Healthcare.

Read Full Report: http://www.transparencymarketresearch.com/crdiovascular-monitoring-diagnostic-devices.html

Vast Geriatric Population Base and Flourishing Medical Tourism Industry Key to Market’s Growth

According to estimates derived by the United Nations University (UNU), the share of people aged above 65 years in the global population is expected to rise from 7% in 2000 to 16% by 2050. As people above the age of 65 years are more prone to acquiring cardiovascular diseases, the vast rise in the world’s geriatric population in the near future will stimulated demand for effective cardiovascular monitoring and diagnostic devices.

Additionally, the flourishing sector of medical tourism in developing countries will have a sizeable impact on the consumption of a variety of cardiovascular monitoring and diagnostic devices in regions such as Asia Pacific and Middle East in the next few years. Low procedural costs and availability of reliable and affordable labor in countries such as Turkey, India, China, and Indonesia will make them the most preferred foreign destinations for undertaking complex cardiovascular diagnosis and surgeries.

Factors such as inadequate physical activities, unhealthy diets, high stress levels, and rising consumption of tobacco and alcohol are substantially increasing risk of cardiovascular disorders in the global population. This has also emerged as a high-impact driver of the global cardiovascular monitoring and diagnostic devices market in the past few years.

View exclusive Global strategic Business Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2385

Lack of Favorable Reimbursement Policies and High Cost of Advanced Devices Challenge Expansion across Developing Economies

For most varieties of cardiovascular monitoring and diagnostic devices available in the market presently, high costs and limited or inadequate reimbursement policies are the key hindrances that limit the overall development of the market to a certain extent. In developed regions such as the U.S., Japan, and many European countries, the high costs of devices are supported by sufficient reimbursement for purchasing these devices and tests. However, post purchase activity costs, involving costs for recording and testing activities are not covered under reimbursement policies, bringing down the attractiveness of high-end cardiovascular monitoring and diagnostic devices, especially across cost-sensitive developing regions.

The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder is expected to expand at the highest CAGR of 7.1% over the period between 2016 and 2024. Geography-wise, Asia Pacific will present the most promising growth opportunities over the said period, expanding at a 7.1% CAGR.

This review of the global cardiovascular monitoring and diagnostic devices market is based on a recent market research report published by Transparency Market Research, titled “Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Computer Aided Detection Market size and Key Trends in terms of volume and value 2016-2024

Computer aided detection (CAD) is a clinically established tool that helps in the diagnosis or detection of cancers, and cardiovascular and neurological diseases. These systems assist physicians to decrease false negative rate, detect cancer at early stages, reduce mortality rates caused due to cancer and other diseases, and improve inter and intra reader variability. Additionally, CAD systems are extensively used to help physicians in numerous tasks that include providing a second opinion to the diagnostic and detection outcomes and automatically recognizing all non-calcified lesions doubted of malignancy at images. A CAD system helps in diagnosis, detection, and risk assessment. The purpose of using a computer and CAD tools is to help in medical image diagnosis. Technologically advanced CAD systems provide a moderately trained physician the same diagnostic skills as an experienced radiologist. CAD has also been used to increase the sensitivity of diagnostic imaging in medical investigation and differential diagnostics.

This research study analyzes the market for computer aided detection in terms of revenue (US$ Mn). The market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. The report also includes key market dynamics, such as drivers, restraints, and opportunities, affecting the demand for computer aided detection products globally and country wise. Comparative analysis has also been included in the executive summary for each region of 2016 and 2024.

Read Full Report: http://www.transparencymarketresearch.com/computer-aided-detection.html

The report provides in-depth analysis of the computer aided detection market. The stakeholders of this report include companies engaged in the manufacture of CAD products used along with medical imaging equipment in screening of cancers and other diseases. The executive summary section is included in this report to provide a snapshot of the market. It summarizes the market size, trends, and competition in different regions.

The market overview section of this report analyzes market dynamics such as drivers, restraints, and opportunities that influence the computer aided detection market in the current and future scenario. Market share analysis is provided to signify percentage share of the major players operating in the computer aided detection market. These factors will help the market players to chalk out business strategies and plans to strengthen their positions in the global market.

Based on application, the computer aided detection market has been segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, other cancers, and other disease. In terms of imaging modality, the market has been segmented into mammography, magnetic resonance imaging, ultrasound imaging, tomosynthesis, CT, and others.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1442

In terms of region, the computer aided detection market has been segmented into four major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries such as the U.S., Canada, Germany, the U.K., Japan China, Russia, Brazil, Mexico, and South Africa have been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market in various regions has been provided in this section.

The report provides market estimation of the computer aided detection market in terms of revenue (US$ Mn) for all the segments and sub segments, with CAGR % for the period from 2016 to 2024, considering 2015 as the base year. Furthermore, the report incorporates market attractiveness analysis by product category that depicts the most attractive product segment in the global market during the forecast period from 2016 to 2024.

This report also includes a recommendations section that will assist new companies to establish their presence and existing market players to expand their market shares in the computer aided detection market. The report concludes with the company profile section, which includes company overview, financial overview, product portfolio, business strategies, and recent developments of market players. Key players profiled in the report include Agfa-Gevaert N.V., Fujifilm Medical Systems USA, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Samsung Medison Co. Ltd, and Philips Healthcare.

Traveler’s Diarrhea Market: Enterotoxigenic Escherichia coli is the most common causative agent

Traveler’s Diarrhea Market: Overview

Traveler’s diarrhea refers to intestinal and stomach infection and occurs due to unsanitary conditions during handling of food. This disorder is characterized by frequent abdominal cramps resulting in loose stools and is usually caused by consumption of contaminated water or food. Travelling from one place to another where the sanitary conditions, social conditions, climate and other factors are different and hence presents high risk of developing traveler’s diarrhea.

This is one of the most common condition affecting travelers every year, for example according to data enumerated by Centers for Disease Control and Prevention (CDC), around 20% to 50% an estimated 10 million of the international traveler’s develop traveler’s diarrhea every year. This disorder occurs during the travel period or post return and also in some cases one can experience multiple episodes of diarrhea during one trip. Developing countries of Latin America, Middle East, Asia and Africa represent the areas for highest risk of contracting traveler’s diarrhea. Immunosuppressed individuals, young adults and individuals with inflammatory bowel disorders and diabetic patients constitute the highly susceptible patient population for contracting traveler’s diarrhea.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13433

Intensity of infection varies depending on the type of eating establishment. For instance, there is low risk of infection if the food is consumed in private homes and poses high risk of infection in the food from the street vendors. Nausea, vomiting, fever, frequent defecate and abdominal cramps are some of the common symptoms of traveler’s diarrhea. Most of the cases are benign and resolve quickly but sometimes sign and symptoms persist for several days and can be more severe in cases where it is caused by other organisms other than common bacteria. In these cases, prescription medicines are recommended for the treatment. Enterotoxigenic Escherichia coli is the most common causative agent of traveler’s diarrhea. Travelers can minimize the risk of developing traveler’s diarrhea by adopting several preventive measures such as use of bottled drinking water, avoiding consumption of raw or uncooked seafood and meat and raw fruits.

Consulting a doctor than self medication is preferred for the treatment of traveler’s diarrhea and especially relevant to pregnant women and children. There are several medications prescribed for the treatment of diarrhea. For example, Pepto-Bismol tablet shortens the duration of illness and decreases diarrhea. This drug is not advised to take for more than three weeks at a time as it results in certain side effects such as temporary blackening of stools and tongue, constipation, nausea and others. Also, the consumption of this is not recommended for the patients who have aspirin allergy, gout, renal insufficiency and who are already taking anticoagulants. Other treatment options are replacement of fluids and salts achieved by the intake of oral rehydration solutions such as oral rehydration salts (ORS).

Traveler’s Diarrhea Market: Segmentation

The market for traveler’s diarrhea can be analyzed by the various medications available for the treatment and the geographical landscape. Antimicrobial therapy is the most preferred one and fluoroquinolones are the most preferred. The geographical landscape elucidates the analysis of the market by four major geographies namely North America, Asia-Pacific, Europe and Rest of the World. In addition, factors such as side effects of the drugs, introduction of alternate therapies, and increased focus on preventive care would impact the market growth.

Furthermore, regulatory policies, marketing approvals for drugs and safety concerns would further influence the market growth. The major factors favoring the market growth are increasing cases of traveler’s diarrhea and growing tourism across the globe. On the other hand, factors such as side effects of the drugs and lack of accessibility to appropriate treatment might encumber the market growth.

Bayer AG, Johnson & Johnson, Merck & Co., Inc. and Novartis AG are some of the companies operating in this market.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Emergence of Innovative Products and Developing Healthcare Sector to Create Opportunities for Hemostasis Products Market Players

Hemostasis is an important procedure that is used for preventing bleeding of an injured or damaged blood vessel. This process is considered as the first stage of wound healing. With the rapid development of the healthcare sector, the global market for hemostasis products is expected to witness substantial growth in the coming years. At present, the market is fragmented and competitive in nature with a large number of players operating in it. As per a research study by Transparency Market Research (TMR), in 2015, the global market for hemostasis products was worth US$5.35 bn and is estimated to reach a value of US$7.73 bn by the end of 2024. The market is estimated to register a 4.20% CAGR between 2016 and 2024.

Read Full Report: http://www.transparencymarketresearch.com/hemostasis-products-market.html

This blog addresses several questions related to the development of the global hemostasis products market. Some of them are given below:

What aspects are likely to encourage the growth of the global hemostasis products market?

The rising focus of key players on technological advancements and innovations is one of the vital factors anticipated to augment global market in the next few years. In addition, the increasing number of research and development activities and the robust development of the healthcare sector are further expected to accelerate the growth of the overall market. The strong pipeline of hemostasis products and the rising number of surgical and trauma cases are some of the other factors estimated to generate promising opportunities for the key players operating in the hemostasis products market across the globe.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13880

Which region is projected to lead in the global hemostasis products market?

Among the key geographical regions, North America is expected to lead the global hemostasis products market in the next few years. The high growth of this region can be attributed to the rising number of innovative and effective products and the increasing pool of patients. In addition, the high-tech healthcare infrastructure and the technological developments related to hemostasis are anticipated to accelerate the growth of the market in the next few years. Furthermore, Europe and Asia Pacific markets are anticipated to witness substantial growth in the coming years.

Which business strategies have been adopted by key players to sustain in the global hemostasis products market?

Abbott Laboratories, Medtronic plc, Baxter International, Inc., Grifols, S.A., Johnson & Johnson, and Pfizer, Inc., are some of the key players operating in the global hemostasis products market. These players are making notable efforts to introduce new products in order to create a niche for themselves and gain a competitive advantage. In addition, the focus on untapped opportunities in the developing economies is expected to contribute extensively towards the growth of the global market. The increasing investments in the research and development activities is projected to bolster global hemostasis products in the next few years.

Interventional Radiology Market: Business Challenges, Emerging Technologies & Competitive Landscape

Global Interventional Radiology Market: Snapshot

The use interventional radiology procedures is witnessing a huge surge across the globe owing to their minimally invasive nature and benefits such as less recovery time and hospital stay. A number of interventional radiology procedures are being regularly used for the treatment of diseases such as cancer, cardiovascular diseases, and traumatic inquiries, the prevalence of which is rising at an alarming rate globally. The field of interventional radiology also holds immense promise owing to the wide range of applications and technological advancements.

As a result, the global interventional radiology market is poised to observe significant growth in the next few years. Transparency Market Research estimates that market will exhibit a CAGR of 5.8% over the period between 2016 and 2024. If the prediction holds true, the market, which valued at US$13.8 bn in 2015, is expected to reach US$22.9 bn by 2024.

Rising Numbers of Traumatic Injuries to Boost Demand for Embolization Procedures

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/interventional-radiology-market.html

In terms of application, the global market for interventional radiology is examined for angiography, balloon angioplasty, embolization, vertebroplasty, biopsy, kyphoplasty, and RF ablation. Of these, the segment of embolization is expected to account for a share of 24.2% of the global market by 2024. The segment also holds the dominant position in the market presently and accounted for a 23.8% of the global market in 2015.

The rising prevalence of traumatic injuries across the globe is expected to drive the increased demand for embolization surgeries worldwide. According to the National Trauma Institute, traumatic injuries account for nearly 41 mn visits to emergency departments and over 2.3 mn hospital admissions. Traumatic injury is also a serious public health issue globally and is expected to lead to an increased demand for embolization surgeries in the near future.

The angiography segment is projected to account for a share of 21.0% in the global market by 2024. The rising global prevalence of strokes and high demand for minimally invasive surgeries will allow the segment to expand at a favorable pace over the forecast period. Biopsy and vertebroplasty-kyphoplasty are relatively smaller segments of the market, with a collective share of nearly 11.8% in the global market in 2015. The segment of biopsy is expected to register a CAGR of 5.6% during the forecast period owing to the increasing prevalence of breast cancer.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1337

Asia Pacific to Lead to Promising Growth Opportunities

With a 38.4% share, the North America interventional radiology market held the top spot in the global market in 2015. Rising demand for minimal invasive procedures and an endless supply of technological advanced devices and equipment are the major factors supporting the growth of the North America market. The x-ray segment gained the leading position in North America in the same year, accounting for over half of the market. Owing to factors such as improvement in technology, rising incidences of a variety of cancers, and well-established healthcare facilities, the North America market for interventional radiology is expected to expand at a swift pace over the next few years as well.

Although North America will continue to account for a higher share in the global interventional radiology market as compared to other regional markets over the forecast period as well, it is expected to lose prominence to the market in Asia Pacific in terms of rate of growth. The Asia Pacific interventional radiology market is expected to exhibit a 7.1% CAGR from 2016 through 2024. Rising prevalence of a variety of cancers, rising geriatric population, improving healthcare facilities, and rising disposable incomes and the relative rise in healthcare spending will play a key role in driving the Asia Pacific interventional radiology market over the said period.

The global interventional radiology market features a consolidated competitive landscape, wherein a relatively small number of companies account for a majority share in the market. Some of the key players operating in the global Interventional Radiology market are Agfa-Gevaert N.V., Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Medtronic plc., and Philips Healthcare.

Mechanical Ventilators Market is poised to reach a value of US$1.8 bn by 2024

Key players in the global mechanical ventilators market include Dragerwerk AG & Co. KGaA, Philips Healthcare, GE Healthcare, Smiths Medical, Becton, Dickinson and Company, Fisher and Paykel Healthcare Limited, Getinge Group, Medtronic Plc, ResMed, and Hamilton Medical AG.

Transparency Market Research finds that the global mechanical ventilators market is characterized by the strong presence of a number of local and regional players. These companies are just as capable as global players in efficiently catering to the changing consumer needs and entering neighboring markets. However, regulatory requirements differing from country to country tend to restrict the entry of these players in several national markets. Nevertheless, large multinational players are entering into strategic partnerships or acquiring small start-up companies in order to match the competition in local markets for mechanical ventilators.

Read Full Report: http://www.transparencymarketresearch.com/mechanical-ventilators-market.html

The global market for mechanical ventilators was worth US$1.1 bn in 2015 and is poised to reach a value of US$1.8 bn by 2024, registering a 4.8% CAGR therein. In terms of volume, the mechanical ventilators market is projected to expand at a CAGR of 5.5% during the forecast period.

Non-invasive Mechanical Ventilators Gaining Preference over Invasive Variants

By type of product, critical care mechanical ventilators contributed the most toward the global market. In terms of percentage share contribution, the segment is anticipated to account for a 48.2% share by 2024. The portable mechanical ventilators segment is expected to exhibit the strongest CAGR of 7.6% from 2016 to 2024 by value.

Based on mode, invasive mechanical ventilators presently form the leading segment of the global market. However, registering a rapid growth rate through 2024, the non-invasive mode segment is expected to reflect a gain in market share by the end of the forecast period. On the basis of end use, hospitals account for the major share in the global mechanical ventilators market in terms of revenue. Home healthcare, on the other hand, is forecast to register the highest growth rate by 2024.

From a geographical standpoint, North America is expected to account for a 39.7% share in the global mechanical ventilators market by 2024 and will continue its dominance during the forecast period. Asia Pacific is the most attractive market and is slated to expand at a CAGR of 5.5% from 2016 to 2024.

Increased Demand for Mechanical Ventilators in Hospitals and Trauma Centers

The World Health Organization reports that more than five million deaths are reported every year owing to chronic respiratory diseases. The deteriorating quality of air, particularly in countries where the economy is largely dependent on pollution-intensive industries, is one of the chief causes of the alarming spike in the prevalence of respiratory diseases, especially chronic obstructive pulmonary disease (COPD). This translates into an increased demand for medical devices, one of which is mechanical ventilators.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1397

“On the backdrop of the constantly growing incidence of reported respiratory diseases, the demand for mechanical ventilators in hospitals and trauma centers has increased and, in recent times, catalyzed the sales of the same,” the author of the report states.

In contrast, the shrinking profit margins of manufacturers, intensive competitive rivalry, budgetary constraints faced by small healthcare facilities, and injuries associated with the prolonged use of ventilators threaten the growth of the global mechanical ventilators market.

Hemostasis Products Market size and Key Trends in terms of volume and value 2016-2024

The global market for hemostasis products presently features the rising introduction of innovative and technologically advanced products, increased patent expiries and the resulting surge in biosimilars and cheaper alternatives, and increased demand across developing economies. Factors such as the vast rise in trauma and surgery cases and the increased investment in research and development activities will help in the favorable development of the market in years to come.

Transparency Market Research states that the global hemostasis products market will expand at a healthy 4.2% CAGR over the period between 2016 and 2024. Growing at this pace, the market, which had a valuation of US$5.35 bn in 2015, is expected to rise to US$7.73 bn in 2024.

Infusible Hemostats Presently Lead but Advanced Hemostats to Witness Promising Growth

Infusible hemostats are among the most common and widely used hemostatic products for a number of bleeding management practices performed on patients suffering from blood clotting disorders such as hemophilia, Von Willebrand disease (vWD), and dysfibrinogenemia. The segment thus held the largest share of over 47% in the global hemostasis products market in 2015. However, the segment is expected to lose its attractiveness and a vast share of its present share in the global market to the segment of advanced hemostats over the period between 2016 and 2024. Over this period, the market for advanced hemostats is expected to rise at a 6.9% CAGR, while segment of infusible hemostats will exhibit a meagre 07% CAGR.

Hemostasis Products Used for Treatment of Hemophilia to Remain Key Contributor to Market’s Growth

Of the key application areas for hemostasis products, including trauma, surgery, hemophilia, myocardial infraction, stroke, and thrombosis, the use of hemostasis products for the treatment of hemophilia was the leading contributor to the global market’s overall revenues in 2015. The segment held an opportunity of US$5.35 bn in 2015 and is expected to witness growth at a substantial pace over the forecasting horizon as well. However, the applications of hemostasis products for the management of trauma cases will be the most promising application segment for the global hemostasis products over the period between 2016 and 2024. Over this period, the segment will expand at a 6% CAGR as compared to the comparatively moderate 4% CAGR that the hemophilia application segment is expected to exhibit.

Vast Untapped Opportunities to Stimulate Demand for Hemostasis Products in Asia Pacific

North America is presently the largest market for hemostasis products, accounting for a 36.1% share in the global market’s revenues in 2015. The region is expected to witness expansion at a substantial pace over the next few years as well. High level of receptiveness to technological advancements, strong economies, and a swarming pool of patients with a variety of blood disorders are the chief factors that will keep North America at the forefront of the global hemostasis products market in the near future.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13880

The rising numbers of trauma cases and complex surgeries, rising geriatric population and high investment is research and development are also driving the hemostasis products market in North America. The market for hemostasis products in Europe, which is the second largest contributor to the global hemostasis products market’s revenues, is also chiefly driven by the abovementioned factors.

Over the period between 2016 and 2024, the market for hemostasis products in Asia Pacific is expected to yield the most promising results for the global hemostasis products market. The vast and continuously rising set of under-served population suffering from bleeding disorders such as hemophilia, especially across developing economies such as India, is expected to boost the adoption of hemostasis products in Asia Pacific. It is estimated that India has the largest number of hemophilia patients in the world, 60-70% of which were undiagnosed in 2015. TMR analysts state that the hemostasis products market in Asia Pacific will expand at a strong CAGR of 5.2% across the key regional markets from 2016 through 2024.

Some of the key vendors operating in the global hemostasis products market are Integra LifeSciences Corporation, C. R. Bard, Inc., Abbott Laboratories, Baxter International, Inc., CSL Behring LLC, HemCon Medical Technologies, Inc., Grifols, S.A., Johnson & Johnson, Medtronic plc, and Pfizer, Inc.

BRICS In vitro Diagnostics Market: China is expected to have the major share

In Vitro Diagnostics Market: Overview

In vitro diagnostics (IVD) is a suite of diagnostic tests performed using analytical instruments and reagents, on samples such as blood, stools, urine, tissues, and other body fluids. These samples are derived from patients or healthy individuals, to detect diseases or infections. Some of the significant technologies incorporated in in vitro diagnostics are polymerase chain reaction (PCR), immunoassays, and sequencing technologies. In vitro diagnostics play significant role in risk assessment, and disease monitoring. Great advances have been achieved lately, particularly in the field of clinical immunology Recombinant allergens have been investigated in diagnosing asthma and food, pollen-induced and insect allergies, in in vitro testing.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12959

In Vitro Diagnostics Market: Segmentation

The market can be segmented across different categories such as product types, applications, end users and geography. Based on product types, the market is segmented into, instruments, data management systems and reagents & kits. Based on application, the market is further segmented into, diabetes, infectious diseases, oncology, cardiology, nephrology, HIV, and other applications. Laboratories, standalone clinics, hospitals and patients form the major end-users of the market.

The in vitro diagnostic market comprises several tests such as thyroid function tests, renal function tests, lipid profiling, liver function tests, basic metabolism tests, immunoassays, Enzyme Linked Immunosorbent Assay (ELISA), radio Immunoassay (RIA), florescent Immunoassay (FIA), hematology, full blood count (RBC, WBC, and platelets), bone marrow testing, blood coagulation tests, biopsy, microbiology, and other IVD techniques.

In Vitro Diagnostics Market: Regional Insight

On basis of geography, the market has been segmented into five countries – Brazil, Russia, India, China, and South Africa. The BRICS IVD market is expected to have a healthy growth rate owing to the booming healthcare industry, thus driving the in vitro diagnostics market. China is expected to have the major share and is likely to remain the largest regional segment of BRICS countries, followed by Brazil, Russia, India, and South Africa.

Rampant economic growth observed in BRICS countries and emerging markets enabling patient base to afford diagnostic services has resulted in steady increase in healthcare expenditure. This is likely to remain an important driver for the BRICS IVD market in coming years. Increased awareness of diseases and personalized medicines, and rising health conscious urban population, combined with growing incidences of infections and diseases, has led to rise in demand for in vitro diagnostics in BRICS countries. Large aging population and prevalence of chronic diseases, combined with government support for healthcare market will drive the in vitro diagnostics market in China.

Brazil Chamber of Laboratory Diagnostics (BCLD) study demonstrated that out of the total in vitro diagnostics market, laboratories comprised 88%, followed by blood banks at 11%, whereas Point of Care (POC) testing centers comprised only 1%. Increasing healthcare budgets along with rising number of private hospitals, and income levels backed by huge untapped population base offer interesting growth opportunities for IVD market in Brazil. However lack of proper reimbursement policies and a stringent regulatory framework may hamper the market growth. IVD market in South Africa has reached a stable phase with growth concentrated around infectious diseases diagnostics. However price sensitivity, lack of reimbursement policies and labor shortages continue to prove a hindrance to the growth of IVD market in South Africa.

In Vitro Diagnostics Market: Key Players

The in vitro diagnostics market is competitive in nature and hence possesses higher threat to new entrants. Some major players of in vitro diagnostics market comprises Roche diagnostics, Siemens Healthcare, Danaher, Abbott Laboratories, Inc., Johnson & Johnson, and Bio Rad laboratories, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Mobility Scooter Market: Comparative High Cost than Wheelchairs is likely to Hinder the Growth of the Market Segment

Mobility scooters are electronic transport vehicles used as a mobility aid, mostly occupied by single person. These mobility scooters are operated on battery and varies from 3 wheels to 5 wheels. Mobility scooters assist in the movement of a person from one place to another, especially long distance travelling. Gasoline-powered scooters are very rare in the market and are being rapidly replaced by electric or battery-powered scooters. Mobility scooters are available in two forms worldwide: front-wheel drive and rear-wheel drive. Front-wheel drive scooters are smaller and are primarily used indoors, whereas the rear-wheel drive scooters are used both outdoors and indoors. The rider weight capacity of a rear-wheel drive scooter is higher than the front-wheel drive scooter. Mobility scooters acts as an alternative to wheelchairs and is expected to have a significant growth rate during the forecast period from 2016-2024. The use of mobility scooters are supported with government funding in most of the regions across the globe. However, comparative high cost than wheelchairs is likely to hinder the growth of the market segment. Thus, the government interventions has made the use of mobility scooter cost effective through various schemes offered to the users. The mobility scooters offers comfort, ease of use and elegance, which instead is not offered by traditional wheelchairs, makes the mobility scooter market more potential.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14141

Moreover, rising geriatric population, increasing incidences of knee and spine disorders, rising accidental and innate deformities are the important factors leading to the growing demand for mobility scooters globally. In order to assist the research and development in mobility aids, various national and international organizations participate actively along with regional government. Various government initiatives such as Affordable Care Act in the U.S., offers subsidy on mobility scooters for patients. Thus, market has high potential to grow in terms of its population reach, which is actively supported by government and non-government bodies. In addition, availability of mobility scooters in different designs and features has increased the attention of users towards mobility scooters. However, lack of infrastructure in many parts of the world and high cost of the devices restricts the uptake to some extent. Moreover, the use of refurbished mobility scooters is another biggest challenge faced by the market.

The mobility scooter market can be segmented into by type of design, by number of wheels, by distribution channel and by geography. In the terms of design, the mobility scooter is classified into boot scooters, mid-sized scooters and on road scooters. By wheels, the mobility scooter is classified into 3 wheels, 4 wheels and 5 wheels mobility scooters. By geography, the U.S. and European regions mainly U.K., occupies significant share of the mobility scooter market. North America dominates the market, due to government policies and high demand for mobility scooters. Moreover, baby boomer effect, sophisticated reimbursement policies, high awareness about the device are the other key factors favoring the market in North America. Followed by North America, Europe accounted for the second largest share of the global mobility scooters market due to increasing awareness and rising disposable income. However, Asia Pacific is expected to grow at a higher growth rate owing to huge untapped population and increasing health care awareness among the patient population.

The major players having presence in the global mobility scooters market include Invacare, Afikim Electric Vehicles., Drive Medical Design and Manufacturing, Golden Technologies Inc., Pride Mobility Products, Hoveround Corp., Sunrise Medical, Van Os Medical, Electric Mobility, Amigo Mobility International Inc., Quingo, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Ventilator Accessories Market: Applications and Global Markets

Ventilators are critical life-support devices that provide respiratory therapy to millions of patients every single day. The ventilator accessories market unveils the characteristics of an increasingly mature market with innovative brands & unique product differentiation in order to secure competitive advantage. The ventilation accessories segment includes flow sensors, breathing sets, expiratory valves, endotracheal tubes, breathing circuits, humidifiers, interfaces, masks & lot more. The relatively inclusive range of end use sectors and specialist applications for innovative ventilator accessories represents a supportive factor in terms of the long term market growth. Large medical device manufacturers are majorly focused on launching novel products in order to accomplish development in the global ventilators market. Companies are also more attentive on collaboration by acquiring domestic and international players to expand their product portfolios and boost their distribution channels in emerging markets. High-tech advancement is another key factor for manufacturers to improve technologies and thus prevent respiratory illness and reduce the time spent on other ventilation procedures. 

Drivers & Restraints

Rising elderly population, growing prevalence of respiratory disorders, and rising number of preterm births are predictable to fuel the growth of ventilators accessories market in the forecast period. Ventilator accessories market growth has been driven by increasing in sales of portable and mechanical ventilators. Furthermore there is also an increase in the relevance of hospitals, medical emergency services and rehabilitation centers can be expected to rise in the demand for ventilators. Industry experts design these accessories utilizing the high grade standard material with high-end technology. Manufacturers are mainly focused for the highest possible patient safety and ease of use. Growing per capita income, extensive R&D investments in the healthcare industry by top market players, rising demand for advanced front-line technologies, and expansion of private hospitals and rehab-centers in remote areas are the major factors driving growth of the ventilators accessories market globally. Also, lack of access to primary care in developing regions is comparatively driving sensitive demand for urgent respiratory care utilization. Patient safety and operator control safety is the prime concern which has been regulated by the few official authorities which has executed huge challenges for the medical device manufacturers. New materials may bring together biocompatibility and circuitry issues.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15299

Global Ventilators Market: Segmentation

The Global Ventilators Market market can be segmented as follows:

Global ventilator accessories market by Product Type

• Flow sensors
• Breathing sets
• Expiratory valves
• Endotracheal tubes
• Breathing circuits
• Humidifiers
• Interfaces and masks
• Others

Global Ventilators Market, by End User

• Hospitals
• Ambulatory Surgery Centres
• Clinics
• Emergency Medical Services
• Long term care centres 

Global Market: Regional Outlook

Geographically, the global ventilator accessories market is segmented into five regions, namely North America, Latin America, Europe, Asia Pacific & the Middle East and Africa (MEA). North America (U.S) is the largest regional segment of the overall ventilator market, followed by Europe region. Currently Asia-Pacific region has also enhanced the growth rate during the forecast period. The rate of efficiency is mainly attributed to the geriatric population worldwide, rising incidences of cardio-vascular & respiratory diseases, extensive growth in healthcare expenditure, and rapidly growing healthcare industry worldwide. These regions are expected to generate the fastest growth rates potentially. 

Global Ventilators Market: Key Players

The key players in the Ventilators market are

• Drägerwerk AG & Co. KGaA
• GE Healthcare Ltd.
• Siemens Healthcare
• ResMed Inc.
• Fisher & Paykel Healthcare Corp. Ltd.
• Hamilton Medical AG
• Invacare Corp.
• CAS Medical Systems Inc.
• Nihon Kohden Corp.
• Nonin Medical Inc.
• Criticare Systems Inc.
• Spacelabs Healthcare Inc.
• Nellcor Puritan Bennett LLC
• ALARIS Medical Systems Inc.
• Criticare Systems Inc.
• Masimo Corp.
• Welch Allyn Inc.

The global market for ventilator accessories market is further expected to witness significant growth over the report’s forecast period owing to the rapid and consistent technological innovation in these medical devices and the rising cases of chronic respiratory disorders among people worldwide.

Live Cell Imaging Market - Worldwide Market Shares, Strategies, and Forecasts 2016 to 2024

Live Cell Imaging Market: Overview

Live cell imaging is the use of time lapse microscopy to study the living cells. The scientists use it to get a better understanding of the biological functions with the help of cellular dynamics. The live cell imaging technique is becoming increasingly popular in the healthcare industry.

The market can be categorized by products, by technologies, by end users and by regions. By product types, the live cell imaging market can be segmented into instruments, consumables and softwares. The instruments segment can be further sub-divided into standalone systems, cell analyzers, microscopes and image capturing devices. By technologies, the market can be segmented into fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), fluorescence in situ hybridization (FISH), ratiometric imaging, total iternal reflection fluorescence microscopy (TRIF), and multiphoton excitation microscopy (MPE) among others. Furthermore, the market can be segmented by applications into pharmaceutical industry, contract research organization, government and academic organization and diagnostic laboratories.

Live Cell Imaging Market: Trends and Opportunities

The rising concern of cancer is one of the major factors behind the growth of increasing demand of this technology. Furthermore, the government is actively taking initiatives to fund cell based research. Moreover the live cell imaging has a wide area of application and it can used to understand dynamic processes and cellular structures. In addition, it can also be used to study cellular integrity, protein trafficking, enzyme activity, localization of molecules, exocytosis and endocytosis among others. Furthermore, the process can also be applied to monitor the molecules in live animals. Moreover, the pharmaceutical companies are increasingly using live cell imaging in research and development in order to develop new medicines. In addition, the live cell imaging is also used for high content screening.

However, the cost of implementing live cell imaging is very high is acting as a restraint for the market. Moreover, the technology requires highly skilled professional in order to study and understand the cell functions. The lack of availability of skilled professional is also expected to restrain the growth of live cell imaging market. However, with increasing investments in training and development programs this factor is expected to have low impact in the long run. In addition, the live cell imaging technique is gradually being applied by pharmaceutical companies to develop personalized medicine. This demand is expected to grow in future.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7688

Live Cell Imaging Market: Geographical and Competitive Dynamics

By geography, the market can be divided into North America, Europe, Asia Pacific and Rest of the world. North America and Europe are the early adapters of technology. Furthermore, government initiatives are being taken in this region for research and development using live cell imaging. U.S. is the largest market for live cell imaging in North America. However, Asia Pacific region is expected to witness robust growth due to presence of developing nations such as India and China.

The key players in the live cell imaging market are Sigma-Aldrich Corporation, Nikon Corporation, GE Healthcare, Carl Zeiss AG, Danaher Corporation, Olympus Corporation and Thermo Fisher Scientific, Inc., Molecular Devices, LLC, Becton, Dickinson and Company and Perkinelmer, Inc. among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Interventional Radiology Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

The global interventional radiology market features a largely consolidated competitive landscape, with the top five players accounting for around 60% of the market in 2015, observes a recent report by Transparency Market Research. These top five vendors, namely Philips Healthcare, Hitachi Medical Corporation, GE Healthcare, Toshiba Medical Systems Corporation, and Siemens Healthcare lead the global market owing to diversified product portfolios, extensive geographical presence, and acquisition strategies. Strong new product development capabilities have also worked in the favor of these companies over the years. With launch of innovative equipment such as the interventional x-ray equipment varieties EchoNavigator, Allura 3D, and FlexVision, these companies are expected to retain their dominance in the next few years as well.

Transparency market Research (TMR) states that the global interventional radiology market was valued at US$13.8 bn in 2015 and is expected to expand at a CAGR of 5.8 % over the period between 2016 and 2024. If the prediction holds true, the market is expected to reach US$22.9 bn by 2024. Of the key applications of interventional radiology, the segment of embolization presently dominates and held a nearly 24% of the market’s overall valuation in 2015. From a geographical perspective, North America dominated, acquiring a nearly 38% of the global market in 2015.

Rising Prevalence of Chronic Diseases and Mounting Global Population of Geriatrics Key to Market Growth

Busy lifestyles, lack of physical activities, and unhealthy habits such as smoking and poor diet are resulting in an epidemic of obesity, associated cardiac conditions, and several other chronic diseases. Chronic diseases are one of the leading causes of mortality and disabilities across the world. The increasing incidence of such conditions is expected to one of the foremost causes of the rising demand for interventional radiology procedures during the forecast period. Moreover, the evolution of new techniques such as optical coherence tomography (OCT) as well as fractional flow reserve (FFR), which is used for stenting patients with multi-vessel disease, are likely to increase the global adoption of interventional radiology techniques over the forecast period.

In addition to these factors, the rising global population of geriatrics is also expected to be one of the key factors driving the global interventional radiology market over the forecast period. Aging is associated with a large number of diseases and disorders. A majority of the geriatric population suffers from cardiovascular, neurological, and orthopedic disorders. The rising number of elderly individuals, therefore, is expected result in the increased demand for surgical interventions or acute care services in the near future.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1337

Lack of Encouraging Reimbursement Policies to Deter Adoption across Several Economies

Several countries on a global front have very limited or almost no reimbursement for intervention radiology products or procedures. Across several key developing economies such as Brazil and India, there has been a reduction in the already low reimbursement for procedures such as angioplasty and products such as cardiac stents owing to the high cost of the surgery and equipment of late. The situation is likely to hamper the growth of the intervention radiology market in the next few years.

In addition to this factor, the global interventional radiology market is also expected to be hampered owing to the high excise duties levied on the manufacturers of medical devices globally. The reduction in the profits of manufacturers owing to such taxes reflect in the increased costs of interventional radiology equipment, adding to the already high cost of procedures.

This review of the market is based on a recent market research report published by Transparency Market Research, titled “Interventional Radiology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024.”

Defibrillators Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

The report is titled “Defibrillators Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”.Studies state that sudden cardiac arrest leads to more than 300,000 deaths per year in U.S. alone and is also a major cause of deaths across the globe. Defibrillators are used for treating sudden cardiac arrest caused due to pulseless ventricular tachycardia, ventricular fibrillation, and cardiac arrhythmias.The report segments the global defibrillators market based on three major criteria: product type, key end-use segments and key regional markets.

A new research report on the global defibrillators market published by Transparency Market Research states that the market will grow at a modest pace over the report’s forecast period. The market, which was valued at US$9.3 billion in 2012, is projected to grow at an excellent 6.2% CAGR between 2013 and 2019 and reach US$14.2 billion by 2019. The key factors driving the market’s growth are the rising global incidence of cardiovascular diseases and disorders, ageing population of baby boomers in the U.S., growing preference for installation of automated external defibrillators (AEDs) at workplaces by many businesses, and rising demand from emerging economies of Asia Pacific and the Middle East.

Based on the type of defibrillator, the report further segments the market into automated external defibrillators (AEDs), advanced life support (ALS) defibrillators, wearable defibrillators, and implantable cardioverter defibrillators (ICDs). Amongst these product types, the segment of implantable defibrillator devices acquired the largest share of revenue in the overall defibrillators market in 2012, followed by the segment of advanced life support defibrillators. The rise in ICD implantations across the globe as a precautionary measure towards the prevention of sudden cardiac arrests is a leading factor backing the high global demand for ICDs.According to the various end-use segments of defibrillator devices, the market is segmented into public or community access, homes, business workplaces, hospitals, and emergency medical services. Over the report’s review period, the segment of hospitals led to more than 90% revenue of the market. The number of AED installations at large hospitals and at business workplaces is also projected to rise over the report’s forecast period, leading to a substantial boost to the overall market in the near future.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1817

Among the key regional markets studied by the report, the market in North America accounted for the largest share of the overall market during the review period. Over the report’s forecast period, however, this market segment is projected to grow at a slower CAGR of 5.7%. The global market is expected to achieve a boost from the Asia Pacific and Middle East regions.

The competitive landscape of the global defibrillators market is consolidated and features a very small number of large players. Some of the key businesses operating in the market include Boston Scientific Corporation, Medtronic, Inc., Biotronik SE& Co.KG, HeartSine Technologies Inc., Defibtech LLC, Philips Healthcare, GE Healthcare Ltd., Nihon Kohden Corporation, Zoll Medical Corporation, and St. Jude Medical Inc.

Dental Implants Market size and Key Trends in terms of volume and value up to 2018

A new market intelligence study by Transparency Market Research presents a detailed overview of the global market for dental implants. The report, titled “Dental Implants Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018”, is available on the company website for sale.

Some of the key factors driving the global dental implants market are the rising geriatric population and rising cases of tooth loss, dental cavities, and a variety of periodontal conditions. Factors such as rising disposable incomes and the willingness to spend money on dental disorders are also expected to drive the global dental implants market. The growing preference for dental implants over dental prosthetics owing to the better hygiene and aesthetics associated with the use of dental implants is also a chief driving factor for the global market.

Dental implants are widely executed and accepted by dentists across the globe. The steady growth of the global dental implants market in the past few years has arisen from an increased demand for improved oral aesthetics and has led to a surge in the number of dental practitioners performing implant surgeries. Technological improvements in implant techniques in the past few years have also led to significant growth of the global dental implant market in the past years.

The report presents a detailed overview of the impact of some of the market’s key drivers, restraints, and trends. A detailed analysis of the regulatory framework of the market and its implications on the market’s future development is also included in the report.

The report segments the market on the basis of three broad criteria: dental implant procedure, dental implant material, and geography. On the basis of geography, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW).

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=224

The report projects that despite the economic slowdown in the past few years, the global dental implants market is projected to witness good development in the near future in all regional markets.

The report also provides a detailed overview of the competitive landscape of the global dental implants market. The report provides detailed business profiles and competitive strategies of some of the key companies in the market, recent developments, and a detailed SWOT analysis of key market vendors to help the reader understand the strengths and weaknesses of the companies, and the threats and opportunities they face in the global dental implants market.

Some of the key companies in the market discussed in the report are Straumann, Nobel Biocare, Zimmer Dental, Astra Tech Implant System, Biomet 3i, OpenCell BioMed (OCBM), Implant Sciences Corporation, Dentsply, DOT GmbH, Able Electropolishing, Orchid Orthopedic Solutions, and Westlake Plastics Company.

Mechanical Ventilators Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

Key players in the global mechanical ventilators market include Dragerwerk AG & Co. KGaA, Philips Healthcare, GE Healthcare, Smiths Medical, Becton, Dickinson and Company, Fisher and Paykel Healthcare Limited, Getinge Group, Medtronic Plc, ResMed, and Hamilton Medical AG.

Transparency Market Research finds that the global mechanical ventilators market is characterized by the strong presence of a number of local and regional players. These companies are just as capable as global players in efficiently catering to the changing consumer needs and entering neighboring markets. However, regulatory requirements differing from country to country tend to restrict the entry of these players in several national markets. Nevertheless, large multinational players are entering into strategic partnerships or acquiring small start-up companies in order to match the competition in local markets for mechanical ventilators.

The global market for mechanical ventilators was worth US$1.1 bn in 2015 and is poised to reach a value of US$1.8 bn by 2024, registering a 4.8% CAGR therein. In terms of volume, the mechanical ventilators market is projected to expand at a CAGR of 5.5% during the forecast period.

Non-invasive Mechanical Ventilators Gaining Preference over Invasive Variants

By type of product, critical care mechanical ventilators contributed the most toward the global market. In terms of percentage share contribution, the segment is anticipated to account for a 48.2% share by 2024. The portable mechanical ventilators segment is expected to exhibit the strongest CAGR of 7.6% from 2016 to 2024 by value.

Based on mode, invasive mechanical ventilators presently form the leading segment of the global market. However, registering a rapid growth rate through 2024, the non-invasive mode segment is expected to reflect a gain in market share by the end of the forecast period. On the basis of end use, hospitals account for the major share in the global mechanical ventilators market in terms of revenue. Home healthcare, on the other hand, is forecast to register the highest growth rate by 2024.

From a geographical standpoint, North America is expected to account for a 39.7% share in the global mechanical ventilators market by 2024 and will continue its dominance during the forecast period. Asia Pacific is the most attractive market and is slated to expand at a CAGR of 5.5% from 2016 to 2024.

Increased Demand for Mechanical Ventilators in Hospitals and Trauma Centers

The World Health Organization reports that more than five million deaths are reported every year owing to chronic respiratory diseases. The deteriorating quality of air, particularly in countries where the economy is largely dependent on pollution-intensive industries, is one of the chief causes of the alarming spike in the prevalence of respiratory diseases, especially chronic obstructive pulmonary disease (COPD). This translates into an increased demand for medical devices, one of which is mechanical ventilators.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1397

“On the backdrop of the constantly growing incidence of reported respiratory diseases, the demand for mechanical ventilators in hospitals and trauma centers has increased and, in recent times, catalyzed the sales of the same,” the author of the report states.

In contrast, the shrinking profit margins of manufacturers, intensive competitive rivalry, budgetary constraints faced by small healthcare facilities, and injuries associated with the prolonged use of ventilators threaten the growth of the global mechanical ventilators market.

This review is based on the findings of a TMR report titled “Mechanical Ventilators Market (Product Type - Critical Care, Neonatal Intensive Care, Portable, and Transport; Mode - Invasive and Non-invasive; End User - Hospitals, Trauma Centers, and Home Healthcare) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Cardiovascular Monitoring and Diagnostic Devices Market - current status and future directions.

Being the leading cause of death and witnessing a high rise in prevalence, the class of ailments that come under the purview of cardiovascular diseases is witnessing increased focus from healthcare, research, and government bodies alike. A large number of companies are venturing into the market with an innovative range of products for diagnosing and treating a variety of cardiovascular diseases. Research and development activities are being granted increasingly more funds and governments bodies are implementing various health schemes aimed at reducing the prevalence and improving awareness about cardiovascular diseases.

Transparency Market Research states that the global cardiovascular monitoring and diagnostic devices market held an opportunity of US$1.8 bn in 2015. The market is expected to expand at a 6.4% CAGR over the period between 2016 and 2024, and rise to a valuation of US$3.1 bn by 2024.

Electrocardiogram (ECG) Systems Lead on Account of Cost Effectiveness and High Efficiency

The product segment of ECG systems presently holds the largest share in the global cardiovascular monitoring and diagnostic devices market. The widespread presence and high preference for ECG systems in developed and developing regions alike are key to the segment’s leading market position. ECG systems are expected to remain the key contributor to the market’s overall revenues over 206 and 2024 as well, expanding at a 6.3% CAGR in the global market.

However, the segment of implantable loop recorders is expected to witness the fastest expansion, a 7.1% CAGR from 2016 to 2024. The segment is projected to benefit from the rising awareness about the use of these devices in diagnosing syncope. As several cases of the disease remain undiagnosed when other conventional diagnostic methods are used, implantable loop recorders are gaining an increased level of adoption across medical diagnostic centers globally. The valuation of the segment is expected to reach US$152.7 mn by 2024.

The segment of Holter monitors also holds immense growth promise owing to the rising prevalence of conditions such as arrhythmia and conduction block. The segment was valued at US$416.1 mn in 2015 and is expected to expand at a high single-digit CAGR from 2016 to 2024.

North America to Continue Taking Largest Share of Pie but Emerging Economies Hold More Promise

North America accounted for the largest share of the overall revenues of the global cardiovascular monitoring and diagnostic devices market in 2015. The region is expected to remain the largest market over the period between 2016 and 2024 as well. Factors such as favorable reimbursement policies, high awareness about available diagnosis and treatment methods among patients and physicians, favorable reimbursement policies, and efficient healthcare infrastructure are factors that will help North America remain at the forefront of the global market. Europe, the second largest contributor to the global cardiovascular monitoring and diagnostic devices market in 2015, will also remain a lucrative owing to large scale healthcare infrastructure development activities and rising prevalence of cardiovascular disease.

View exclusive Global strategic Business Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2385

However, developing regions such as Latin America and Asia Pacific will present the most promising growth opportunities for the global cardiovascular monitoring and diagnostic devices market over the period between 2016 and 2024. The presence of vast untapped growth prospects, rising healthcare expenditure, and increasing awareness about the efficiency of available techniques and devices in effectively curing several cardiovascular conditions will remain key to the overall growth of the market.

Several research studies also state that the risk of cardiovascular diseases is substantially high in mid- and low-income economies. This substantiates the fact that a large variety of cardiovascular monitoring and diagnostic devices will be consumed in Asia Pacific and Latin America in the next few years. The market for these devices will expand at a 7.5% in Asia Pacific and a 7.3% CAGR in Latin America over the period between 2016 and 2024.

In the highly dynamic global market for cardiovascular monitoring and diagnostic devices market, the top two vendors, GE Healthcare and Philips Healthcare accounted for a more than 55% of the global market in 2015. Other key vendors in the market are Spacelabs Healthcare, St. Jude Medical, Inc., and Siemens Healthcare.